COVID-19 Impact on Global Gene Therapy in Oncology Market Size, Status and Forecast 2020-2026
Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Therapy in Oncology market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapy in Oncology industry.
Based on our recent survey, we have several different scenarios about the Gene Therapy in Oncology YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Therapy in Oncology will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy in Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy in Oncology market in terms of revenue.
Players, stakeholders, and other participants in the global Gene Therapy in Oncology market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Therapy in Oncology market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapy in Oncology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy in Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy in Oncology market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Gene Therapy in Oncology market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Gene Therapy in Oncology industry.
Based on our recent survey, we have several different scenarios about the Gene Therapy in Oncology YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Gene Therapy in Oncology will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gene Therapy in Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gene Therapy in Oncology market in terms of revenue.
Players, stakeholders, and other participants in the global Gene Therapy in Oncology market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Gene Therapy in Oncology market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Gene Therapy in Oncology market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gene Therapy in Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gene Therapy in Oncology market.
The following players are covered in this report:
- Bristol-Myers Squibb
- Cold Genesys
- Advantagene
- Amgen
- AstraZeneca
- Bio-Path Holdings
- CRISPR Therapeutics
- Editas Medicine
- Geron Corp
- Idera Pharmaceuticals
- Intellia Therapeutics
- Johnson & Johnson
- Marsala Biotech
- Merck
- Mologen AG
- Oncolytics Biotech
- Oncosec
- Oncotelic
- Shenzhen SiBiono GeneTech
- Sillajen Biotherapeutics
- Tocagen
- UniQure
- Ziopharm Oncology
- Ex Vivo
- In Vivo
- Hospitals
- Diagnostics Centers
- Research Institutes
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy in Oncology Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex Vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy in Oncology Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapy in Oncology Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapy in Oncology Industry
1.6.1.1 Gene Therapy in Oncology Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapy in Oncology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapy in Oncology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Gene Therapy in Oncology Market Perspective (2015-2026)
2.2 Gene Therapy in Oncology Growth Trends by Regions
2.2.1 Gene Therapy in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy in Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy in Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapy in Oncology Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy in Oncology Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapy in Oncology Players by Market Size
3.1.1 Global Top Gene Therapy in Oncology Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy in Oncology Market Concentration Ratio
3.2.1 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy in Oncology Revenue in 2019
3.3 Gene Therapy in Oncology Key Players Head office and Area Served
3.4 Key Players Gene Therapy in Oncology Product Solution and Service
3.5 Date of Enter into Gene Therapy in Oncology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gene Therapy in Oncology Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy in Oncology Forecasted Market Size by Type (2021-2026)
5 GENE THERAPY IN ONCOLOGY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gene Therapy in Oncology Market Size by Application (2015-2020)
5.2 Global Gene Therapy in Oncology Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gene Therapy in Oncology Market Size (2015-2020)
6.2 Gene Therapy in Oncology Key Players in North America (2019-2020)
6.3 North America Gene Therapy in Oncology Market Size by Type (2015-2020)
6.4 North America Gene Therapy in Oncology Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Gene Therapy in Oncology Market Size (2015-2020)
7.2 Gene Therapy in Oncology Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy in Oncology Market Size by Type (2015-2020)
7.4 Europe Gene Therapy in Oncology Market Size by Application (2015-2020)
8 CHINA
8.1 China Gene Therapy in Oncology Market Size (2015-2020)
8.2 Gene Therapy in Oncology Key Players in China (2019-2020)
8.3 China Gene Therapy in Oncology Market Size by Type (2015-2020)
8.4 China Gene Therapy in Oncology Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Gene Therapy in Oncology Market Size (2015-2020)
9.2 Gene Therapy in Oncology Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy in Oncology Market Size by Type (2015-2020)
9.4 Japan Gene Therapy in Oncology Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Gene Therapy in Oncology Market Size (2015-2020)
10.2 Gene Therapy in Oncology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy in Oncology Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy in Oncology Market Size by Application (2015-2020)
11 INDIA
11.1 India Gene Therapy in Oncology Market Size (2015-2020)
11.2 Gene Therapy in Oncology Key Players in India (2019-2020)
11.3 India Gene Therapy in Oncology Market Size by Type (2015-2020)
11.4 India Gene Therapy in Oncology Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Gene Therapy in Oncology Market Size (2015-2020)
12.2 Gene Therapy in Oncology Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy in Oncology Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy in Oncology Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Introduction
13.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Cold Genesys
13.2.1 Cold Genesys Company Details
13.2.2 Cold Genesys Business Overview and Its Total Revenue
13.2.3 Cold Genesys Gene Therapy in Oncology Introduction
13.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2015-2020)
13.2.5 Cold Genesys Recent Development
13.3 Advantagene
13.3.1 Advantagene Company Details
13.3.2 Advantagene Business Overview and Its Total Revenue
13.3.3 Advantagene Gene Therapy in Oncology Introduction
13.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2015-2020)
13.3.5 Advantagene Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview and Its Total Revenue
13.4.3 Amgen Gene Therapy in Oncology Introduction
13.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview and Its Total Revenue
13.5.3 AstraZeneca Gene Therapy in Oncology Introduction
13.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Bio-Path Holdings
13.6.1 Bio-Path Holdings Company Details
13.6.2 Bio-Path Holdings Business Overview and Its Total Revenue
13.6.3 Bio-Path Holdings Gene Therapy in Oncology Introduction
13.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2015-2020)
13.6.5 Bio-Path Holdings Recent Development
13.7 CRISPR Therapeutics
13.7.1 CRISPR Therapeutics Company Details
13.7.2 CRISPR Therapeutics Business Overview and Its Total Revenue
13.7.3 CRISPR Therapeutics Gene Therapy in Oncology Introduction
13.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
13.7.5 CRISPR Therapeutics Recent Development
13.8 Editas Medicine
13.8.1 Editas Medicine Company Details
13.8.2 Editas Medicine Business Overview and Its Total Revenue
13.8.3 Editas Medicine Gene Therapy in Oncology Introduction
13.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2015-2020)
13.8.5 Editas Medicine Recent Development
13.9 Geron Corp
13.9.1 Geron Corp Company Details
13.9.2 Geron Corp Business Overview and Its Total Revenue
13.9.3 Geron Corp Gene Therapy in Oncology Introduction
13.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2015-2020)
13.9.5 Geron Corp Recent Development
13.10 Idera Pharmaceuticals
13.10.1 Idera Pharmaceuticals Company Details
13.10.2 Idera Pharmaceuticals Business Overview and Its Total Revenue
13.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Introduction
13.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2015-2020)
13.10.5 Idera Pharmaceuticals Recent Development
13.11 Intellia Therapeutics
10.11.1 Intellia Therapeutics Company Details
10.11.2 Intellia Therapeutics Business Overview and Its Total Revenue
10.11.3 Intellia Therapeutics Gene Therapy in Oncology Introduction
10.11.4 Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
10.11.5 Intellia Therapeutics Recent Development
13.12 Johnson & Johnson
10.12.1 Johnson & Johnson Company Details
10.12.2 Johnson & Johnson Business Overview and Its Total Revenue
10.12.3 Johnson & Johnson Gene Therapy in Oncology Introduction
10.12.4 Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2015-2020)
10.12.5 Johnson & Johnson Recent Development
13.13 Marsala Biotech
10.13.1 Marsala Biotech Company Details
10.13.2 Marsala Biotech Business Overview and Its Total Revenue
10.13.3 Marsala Biotech Gene Therapy in Oncology Introduction
10.13.4 Marsala Biotech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.13.5 Marsala Biotech Recent Development
13.14 Merck
10.14.1 Merck Company Details
10.14.2 Merck Business Overview and Its Total Revenue
10.14.3 Merck Gene Therapy in Oncology Introduction
10.14.4 Merck Revenue in Gene Therapy in Oncology Business (2015-2020)
10.14.5 Merck Recent Development
13.15 Mologen AG
10.15.1 Mologen AG Company Details
10.15.2 Mologen AG Business Overview and Its Total Revenue
10.15.3 Mologen AG Gene Therapy in Oncology Introduction
10.15.4 Mologen AG Revenue in Gene Therapy in Oncology Business (2015-2020)
10.15.5 Mologen AG Recent Development
13.16 Oncolytics Biotech
10.16.1 Oncolytics Biotech Company Details
10.16.2 Oncolytics Biotech Business Overview and Its Total Revenue
10.16.3 Oncolytics Biotech Gene Therapy in Oncology Introduction
10.16.4 Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.16.5 Oncolytics Biotech Recent Development
13.17 Oncosec
10.17.1 Oncosec Company Details
10.17.2 Oncosec Business Overview and Its Total Revenue
10.17.3 Oncosec Gene Therapy in Oncology Introduction
10.17.4 Oncosec Revenue in Gene Therapy in Oncology Business (2015-2020)
10.17.5 Oncosec Recent Development
13.18 Oncotelic
10.18.1 Oncotelic Company Details
10.18.2 Oncotelic Business Overview and Its Total Revenue
10.18.3 Oncotelic Gene Therapy in Oncology Introduction
10.18.4 Oncotelic Revenue in Gene Therapy in Oncology Business (2015-2020)
10.18.5 Oncotelic Recent Development
13.19 Shenzhen SiBiono GeneTech
10.19.1 Shenzhen SiBiono GeneTech Company Details
10.19.2 Shenzhen SiBiono GeneTech Business Overview and Its Total Revenue
10.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Introduction
10.19.4 Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.19.5 Shenzhen SiBiono GeneTech Recent Development
13.20 Sillajen Biotherapeutics
10.20.1 Sillajen Biotherapeutics Company Details
10.20.2 Sillajen Biotherapeutics Business Overview and Its Total Revenue
10.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Introduction
10.20.4 Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
10.20.5 Sillajen Biotherapeutics Recent Development
13.21 Tocagen
10.21.1 Tocagen Company Details
10.21.2 Tocagen Business Overview and Its Total Revenue
10.21.3 Tocagen Gene Therapy in Oncology Introduction
10.21.4 Tocagen Revenue in Gene Therapy in Oncology Business (2015-2020)
10.21.5 Tocagen Recent Development
13.22 UniQure
10.22.1 UniQure Company Details
10.22.2 UniQure Business Overview and Its Total Revenue
10.22.3 UniQure Gene Therapy in Oncology Introduction
10.22.4 UniQure Revenue in Gene Therapy in Oncology Business (2015-2020)
10.22.5 UniQure Recent Development
13.23 Ziopharm Oncology
10.23.1 Ziopharm Oncology Company Details
10.23.2 Ziopharm Oncology Business Overview and Its Total Revenue
10.23.3 Ziopharm Oncology Gene Therapy in Oncology Introduction
10.23.4 Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2015-2020)
10.23.5 Ziopharm Oncology Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Gene Therapy in Oncology Revenue
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ex Vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy in Oncology Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostics Centers
1.5.4 Research Institutes
1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapy in Oncology Industry Impact
1.6.1 How the Covid-19 is Affecting the Gene Therapy in Oncology Industry
1.6.1.1 Gene Therapy in Oncology Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Gene Therapy in Oncology Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Gene Therapy in Oncology Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Gene Therapy in Oncology Market Perspective (2015-2026)
2.2 Gene Therapy in Oncology Growth Trends by Regions
2.2.1 Gene Therapy in Oncology Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Gene Therapy in Oncology Historic Market Share by Regions (2015-2020)
2.2.3 Gene Therapy in Oncology Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Gene Therapy in Oncology Market Growth Strategy
2.3.6 Primary Interviews with Key Gene Therapy in Oncology Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Gene Therapy in Oncology Players by Market Size
3.1.1 Global Top Gene Therapy in Oncology Players by Revenue (2015-2020)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2015-2020)
3.1.3 Global Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Gene Therapy in Oncology Market Concentration Ratio
3.2.1 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Gene Therapy in Oncology Revenue in 2019
3.3 Gene Therapy in Oncology Key Players Head office and Area Served
3.4 Key Players Gene Therapy in Oncology Product Solution and Service
3.5 Date of Enter into Gene Therapy in Oncology Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Gene Therapy in Oncology Historic Market Size by Type (2015-2020)
4.2 Global Gene Therapy in Oncology Forecasted Market Size by Type (2021-2026)
5 GENE THERAPY IN ONCOLOGY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Gene Therapy in Oncology Market Size by Application (2015-2020)
5.2 Global Gene Therapy in Oncology Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Gene Therapy in Oncology Market Size (2015-2020)
6.2 Gene Therapy in Oncology Key Players in North America (2019-2020)
6.3 North America Gene Therapy in Oncology Market Size by Type (2015-2020)
6.4 North America Gene Therapy in Oncology Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Gene Therapy in Oncology Market Size (2015-2020)
7.2 Gene Therapy in Oncology Key Players in Europe (2019-2020)
7.3 Europe Gene Therapy in Oncology Market Size by Type (2015-2020)
7.4 Europe Gene Therapy in Oncology Market Size by Application (2015-2020)
8 CHINA
8.1 China Gene Therapy in Oncology Market Size (2015-2020)
8.2 Gene Therapy in Oncology Key Players in China (2019-2020)
8.3 China Gene Therapy in Oncology Market Size by Type (2015-2020)
8.4 China Gene Therapy in Oncology Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Gene Therapy in Oncology Market Size (2015-2020)
9.2 Gene Therapy in Oncology Key Players in Japan (2019-2020)
9.3 Japan Gene Therapy in Oncology Market Size by Type (2015-2020)
9.4 Japan Gene Therapy in Oncology Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Gene Therapy in Oncology Market Size (2015-2020)
10.2 Gene Therapy in Oncology Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Gene Therapy in Oncology Market Size by Type (2015-2020)
10.4 Southeast Asia Gene Therapy in Oncology Market Size by Application (2015-2020)
11 INDIA
11.1 India Gene Therapy in Oncology Market Size (2015-2020)
11.2 Gene Therapy in Oncology Key Players in India (2019-2020)
11.3 India Gene Therapy in Oncology Market Size by Type (2015-2020)
11.4 India Gene Therapy in Oncology Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Gene Therapy in Oncology Market Size (2015-2020)
12.2 Gene Therapy in Oncology Key Players in Central & South America (2019-2020)
12.3 Central & South America Gene Therapy in Oncology Market Size by Type (2015-2020)
12.4 Central & South America Gene Therapy in Oncology Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
13.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Introduction
13.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Cold Genesys
13.2.1 Cold Genesys Company Details
13.2.2 Cold Genesys Business Overview and Its Total Revenue
13.2.3 Cold Genesys Gene Therapy in Oncology Introduction
13.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2015-2020)
13.2.5 Cold Genesys Recent Development
13.3 Advantagene
13.3.1 Advantagene Company Details
13.3.2 Advantagene Business Overview and Its Total Revenue
13.3.3 Advantagene Gene Therapy in Oncology Introduction
13.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2015-2020)
13.3.5 Advantagene Recent Development
13.4 Amgen
13.4.1 Amgen Company Details
13.4.2 Amgen Business Overview and Its Total Revenue
13.4.3 Amgen Gene Therapy in Oncology Introduction
13.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2015-2020)
13.4.5 Amgen Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview and Its Total Revenue
13.5.3 AstraZeneca Gene Therapy in Oncology Introduction
13.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Bio-Path Holdings
13.6.1 Bio-Path Holdings Company Details
13.6.2 Bio-Path Holdings Business Overview and Its Total Revenue
13.6.3 Bio-Path Holdings Gene Therapy in Oncology Introduction
13.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2015-2020)
13.6.5 Bio-Path Holdings Recent Development
13.7 CRISPR Therapeutics
13.7.1 CRISPR Therapeutics Company Details
13.7.2 CRISPR Therapeutics Business Overview and Its Total Revenue
13.7.3 CRISPR Therapeutics Gene Therapy in Oncology Introduction
13.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
13.7.5 CRISPR Therapeutics Recent Development
13.8 Editas Medicine
13.8.1 Editas Medicine Company Details
13.8.2 Editas Medicine Business Overview and Its Total Revenue
13.8.3 Editas Medicine Gene Therapy in Oncology Introduction
13.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2015-2020)
13.8.5 Editas Medicine Recent Development
13.9 Geron Corp
13.9.1 Geron Corp Company Details
13.9.2 Geron Corp Business Overview and Its Total Revenue
13.9.3 Geron Corp Gene Therapy in Oncology Introduction
13.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2015-2020)
13.9.5 Geron Corp Recent Development
13.10 Idera Pharmaceuticals
13.10.1 Idera Pharmaceuticals Company Details
13.10.2 Idera Pharmaceuticals Business Overview and Its Total Revenue
13.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Introduction
13.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2015-2020)
13.10.5 Idera Pharmaceuticals Recent Development
13.11 Intellia Therapeutics
10.11.1 Intellia Therapeutics Company Details
10.11.2 Intellia Therapeutics Business Overview and Its Total Revenue
10.11.3 Intellia Therapeutics Gene Therapy in Oncology Introduction
10.11.4 Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
10.11.5 Intellia Therapeutics Recent Development
13.12 Johnson & Johnson
10.12.1 Johnson & Johnson Company Details
10.12.2 Johnson & Johnson Business Overview and Its Total Revenue
10.12.3 Johnson & Johnson Gene Therapy in Oncology Introduction
10.12.4 Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2015-2020)
10.12.5 Johnson & Johnson Recent Development
13.13 Marsala Biotech
10.13.1 Marsala Biotech Company Details
10.13.2 Marsala Biotech Business Overview and Its Total Revenue
10.13.3 Marsala Biotech Gene Therapy in Oncology Introduction
10.13.4 Marsala Biotech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.13.5 Marsala Biotech Recent Development
13.14 Merck
10.14.1 Merck Company Details
10.14.2 Merck Business Overview and Its Total Revenue
10.14.3 Merck Gene Therapy in Oncology Introduction
10.14.4 Merck Revenue in Gene Therapy in Oncology Business (2015-2020)
10.14.5 Merck Recent Development
13.15 Mologen AG
10.15.1 Mologen AG Company Details
10.15.2 Mologen AG Business Overview and Its Total Revenue
10.15.3 Mologen AG Gene Therapy in Oncology Introduction
10.15.4 Mologen AG Revenue in Gene Therapy in Oncology Business (2015-2020)
10.15.5 Mologen AG Recent Development
13.16 Oncolytics Biotech
10.16.1 Oncolytics Biotech Company Details
10.16.2 Oncolytics Biotech Business Overview and Its Total Revenue
10.16.3 Oncolytics Biotech Gene Therapy in Oncology Introduction
10.16.4 Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.16.5 Oncolytics Biotech Recent Development
13.17 Oncosec
10.17.1 Oncosec Company Details
10.17.2 Oncosec Business Overview and Its Total Revenue
10.17.3 Oncosec Gene Therapy in Oncology Introduction
10.17.4 Oncosec Revenue in Gene Therapy in Oncology Business (2015-2020)
10.17.5 Oncosec Recent Development
13.18 Oncotelic
10.18.1 Oncotelic Company Details
10.18.2 Oncotelic Business Overview and Its Total Revenue
10.18.3 Oncotelic Gene Therapy in Oncology Introduction
10.18.4 Oncotelic Revenue in Gene Therapy in Oncology Business (2015-2020)
10.18.5 Oncotelic Recent Development
13.19 Shenzhen SiBiono GeneTech
10.19.1 Shenzhen SiBiono GeneTech Company Details
10.19.2 Shenzhen SiBiono GeneTech Business Overview and Its Total Revenue
10.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Introduction
10.19.4 Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2015-2020)
10.19.5 Shenzhen SiBiono GeneTech Recent Development
13.20 Sillajen Biotherapeutics
10.20.1 Sillajen Biotherapeutics Company Details
10.20.2 Sillajen Biotherapeutics Business Overview and Its Total Revenue
10.20.3 Sillajen Biotherapeutics Gene Therapy in Oncology Introduction
10.20.4 Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2015-2020)
10.20.5 Sillajen Biotherapeutics Recent Development
13.21 Tocagen
10.21.1 Tocagen Company Details
10.21.2 Tocagen Business Overview and Its Total Revenue
10.21.3 Tocagen Gene Therapy in Oncology Introduction
10.21.4 Tocagen Revenue in Gene Therapy in Oncology Business (2015-2020)
10.21.5 Tocagen Recent Development
13.22 UniQure
10.22.1 UniQure Company Details
10.22.2 UniQure Business Overview and Its Total Revenue
10.22.3 UniQure Gene Therapy in Oncology Introduction
10.22.4 UniQure Revenue in Gene Therapy in Oncology Business (2015-2020)
10.22.5 UniQure Recent Development
13.23 Ziopharm Oncology
10.23.1 Ziopharm Oncology Company Details
10.23.2 Ziopharm Oncology Business Overview and Its Total Revenue
10.23.3 Ziopharm Oncology Gene Therapy in Oncology Introduction
10.23.4 Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2015-2020)
10.23.5 Ziopharm Oncology Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Gene Therapy in Oncology Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Therapy in Oncology Revenue
Table 3. Ranking of Global Top Gene Therapy in Oncology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Therapy in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ex Vivo
Table 6. Key Players of In Vivo
Table 7. COVID-19 Impact Global Market: (Four Gene Therapy in Oncology Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gene Therapy in Oncology Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gene Therapy in Oncology Players to Combat Covid-19 Impact
Table 12. Global Gene Therapy in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gene Therapy in Oncology Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gene Therapy in Oncology Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gene Therapy in Oncology Market Share by Regions (2015-2020)
Table 16. Global Gene Therapy in Oncology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gene Therapy in Oncology Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gene Therapy in Oncology Market Growth Strategy
Table 22. Main Points Interviewed from Key Gene Therapy in Oncology Players
Table 23. Global Gene Therapy in Oncology Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gene Therapy in Oncology Market Share by Players (2015-2020)
Table 25. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy in Oncology as of 2019)
Table 26. Global Gene Therapy in Oncology by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gene Therapy in Oncology Product Solution and Service
Table 29. Date of Enter into Gene Therapy in Oncology Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gene Therapy in Oncology Market Size Share by Type (2015-2020)
Table 33. Global Gene Therapy in Oncology Revenue Market Share by Type (2021-2026)
Table 34. Global Gene Therapy in Oncology Market Size Share by Application (2015-2020)
Table 35. Global Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gene Therapy in Oncology Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 39. North America Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 41. North America Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 43. Europe Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 45. Europe Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 47. Europe Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 49. China Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 51. China Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 52. China Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 53. China Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 54. China Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 55. Japan Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 57. Japan Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 59. Japan Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 63. Southeast Asia Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 65. Southeast Asia Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 67. India Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 69. India Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 70. India Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 71. India Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 72. India Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 75. Central & South America Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 77. Central & South America Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Product
Table 82. Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Cold Genesys Company Details
Table 85. Cold Genesys Business Overview
Table 86. Cold Genesys Product
Table 87. Cold Genesys Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 88. Cold Genesys Recent Development
Table 89. Advantagene Company Details
Table 90. Advantagene Business Overview
Table 91. Advantagene Product
Table 92. Advantagene Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 93. Advantagene Recent Development
Table 94. Amgen Company Details
Table 95. Amgen Business Overview
Table 96. Amgen Product
Table 97. Amgen Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 98. Amgen Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Product
Table 102. AstraZeneca Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 103. AstraZeneca Recent Development
Table 104. Bio-Path Holdings Company Details
Table 105. Bio-Path Holdings Business Overview
Table 106. Bio-Path Holdings Product
Table 107. Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 108. Bio-Path Holdings Recent Development
Table 109. CRISPR Therapeutics Company Details
Table 110. CRISPR Therapeutics Business Overview
Table 111. CRISPR Therapeutics Product
Table 112. CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 113. CRISPR Therapeutics Recent Development
Table 114. Editas Medicine Business Overview
Table 115. Editas Medicine Product
Table 116. Editas Medicine Company Details
Table 117. Editas Medicine Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 118. Editas Medicine Recent Development
Table 119. Geron Corp Company Details
Table 120. Geron Corp Business Overview
Table 121. Geron Corp Product
Table 122. Geron Corp Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 123. Geron Corp Recent Development
Table 124. Idera Pharmaceuticals Company Details
Table 125. Idera Pharmaceuticals Business Overview
Table 126. Idera Pharmaceuticals Product
Table 127. Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 128. Idera Pharmaceuticals Recent Development
Table 129. Intellia Therapeutics Company Details
Table 130. Intellia Therapeutics Business Overview
Table 131. Intellia Therapeutics Product
Table 132. Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 133. Intellia Therapeutics Recent Development
Table 134. Johnson & Johnson Company Details
Table 135. Johnson & Johnson Business Overview
Table 136. Johnson & Johnson Product
Table 137. Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 138. Johnson & Johnson Recent Development
Table 139. Marsala Biotech Company Details
Table 140. Marsala Biotech Business Overview
Table 141. Marsala Biotech Product
Table 142. Marsala Biotech Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 143. Marsala Biotech Recent Development
Table 144. Merck Company Details
Table 145. Merck Business Overview
Table 146. Merck Product
Table 147. Merck Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 148. Merck Recent Development
Table 149. Mologen AG Company Details
Table 150. Mologen AG Business Overview
Table 151. Mologen AG Product
Table 152. Mologen AG Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 153. Mologen AG Recent Development
Table 154. Oncolytics Biotech Company Details
Table 155. Oncolytics Biotech Business Overview
Table 156. Oncolytics Biotech Product
Table 157. Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 158. Oncolytics Biotech Recent Development
Table 159. Oncosec Company Details
Table 160. Oncosec Business Overview
Table 161. Oncosec Product
Table 162. Oncosec Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 163. Oncosec Recent Development
Table 164. Oncotelic Company Details
Table 165. Oncotelic Business Overview
Table 166. Oncotelic Product
Table 167. Oncotelic Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 168. Oncotelic Recent Development
Table 169. Shenzhen SiBiono GeneTech Company Details
Table 170. Shenzhen SiBiono GeneTech Business Overview
Table 171. Shenzhen SiBiono GeneTech Product
Table 172. Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 173. Shenzhen SiBiono GeneTech Recent Development
Table 174. Sillajen Biotherapeutics Company Details
Table 175. Sillajen Biotherapeutics Business Overview
Table 176. Sillajen Biotherapeutics Product
Table 177. Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 178. Sillajen Biotherapeutics Recent Development
Table 179. Tocagen Company Details
Table 180. Tocagen Business Overview
Table 181. Tocagen Product
Table 182. Tocagen Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 183. Tocagen Recent Development
Table 184. UniQure Company Details
Table 185. UniQure Business Overview
Table 186. UniQure Product
Table 187. UniQure Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 188. UniQure Recent Development
Table 189. Ziopharm Oncology Company Details
Table 190. Ziopharm Oncology Business Overview
Table 191. Ziopharm Oncology Product
Table 192. Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 193. Ziopharm Oncology Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
Table 1. Gene Therapy in Oncology Key Market Segments
Table 2. Key Players Covered: Ranking by Gene Therapy in Oncology Revenue
Table 3. Ranking of Global Top Gene Therapy in Oncology Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Gene Therapy in Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Ex Vivo
Table 6. Key Players of In Vivo
Table 7. COVID-19 Impact Global Market: (Four Gene Therapy in Oncology Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Gene Therapy in Oncology Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Gene Therapy in Oncology Players to Combat Covid-19 Impact
Table 12. Global Gene Therapy in Oncology Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Gene Therapy in Oncology Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Gene Therapy in Oncology Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Gene Therapy in Oncology Market Share by Regions (2015-2020)
Table 16. Global Gene Therapy in Oncology Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Gene Therapy in Oncology Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Gene Therapy in Oncology Market Growth Strategy
Table 22. Main Points Interviewed from Key Gene Therapy in Oncology Players
Table 23. Global Gene Therapy in Oncology Revenue by Players (2015-2020) (Million US$)
Table 24. Global Gene Therapy in Oncology Market Share by Players (2015-2020)
Table 25. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy in Oncology as of 2019)
Table 26. Global Gene Therapy in Oncology by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Gene Therapy in Oncology Product Solution and Service
Table 29. Date of Enter into Gene Therapy in Oncology Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 32. Global Gene Therapy in Oncology Market Size Share by Type (2015-2020)
Table 33. Global Gene Therapy in Oncology Revenue Market Share by Type (2021-2026)
Table 34. Global Gene Therapy in Oncology Market Size Share by Application (2015-2020)
Table 35. Global Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 36. Global Gene Therapy in Oncology Market Size Share by Application (2021-2026)
Table 37. North America Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 39. North America Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 40. North America Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 41. North America Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 42. North America Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 43. Europe Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 45. Europe Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 47. Europe Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 49. China Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 50. China Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 51. China Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 52. China Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 53. China Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 54. China Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 55. Japan Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 57. Japan Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 59. Japan Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 63. Southeast Asia Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 65. Southeast Asia Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 67. India Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 68. India Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 69. India Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 70. India Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 71. India Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 72. India Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Gene Therapy in Oncology Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Gene Therapy in Oncology Market Share (2019-2020)
Table 75. Central & South America Gene Therapy in Oncology Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Gene Therapy in Oncology Market Share by Type (2015-2020)
Table 77. Central & South America Gene Therapy in Oncology Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Gene Therapy in Oncology Market Share by Application (2015-2020)
Table 79. Bristol-Myers Squibb Company Details
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Product
Table 82. Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. Cold Genesys Company Details
Table 85. Cold Genesys Business Overview
Table 86. Cold Genesys Product
Table 87. Cold Genesys Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 88. Cold Genesys Recent Development
Table 89. Advantagene Company Details
Table 90. Advantagene Business Overview
Table 91. Advantagene Product
Table 92. Advantagene Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 93. Advantagene Recent Development
Table 94. Amgen Company Details
Table 95. Amgen Business Overview
Table 96. Amgen Product
Table 97. Amgen Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 98. Amgen Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Product
Table 102. AstraZeneca Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 103. AstraZeneca Recent Development
Table 104. Bio-Path Holdings Company Details
Table 105. Bio-Path Holdings Business Overview
Table 106. Bio-Path Holdings Product
Table 107. Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 108. Bio-Path Holdings Recent Development
Table 109. CRISPR Therapeutics Company Details
Table 110. CRISPR Therapeutics Business Overview
Table 111. CRISPR Therapeutics Product
Table 112. CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 113. CRISPR Therapeutics Recent Development
Table 114. Editas Medicine Business Overview
Table 115. Editas Medicine Product
Table 116. Editas Medicine Company Details
Table 117. Editas Medicine Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 118. Editas Medicine Recent Development
Table 119. Geron Corp Company Details
Table 120. Geron Corp Business Overview
Table 121. Geron Corp Product
Table 122. Geron Corp Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 123. Geron Corp Recent Development
Table 124. Idera Pharmaceuticals Company Details
Table 125. Idera Pharmaceuticals Business Overview
Table 126. Idera Pharmaceuticals Product
Table 127. Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 128. Idera Pharmaceuticals Recent Development
Table 129. Intellia Therapeutics Company Details
Table 130. Intellia Therapeutics Business Overview
Table 131. Intellia Therapeutics Product
Table 132. Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 133. Intellia Therapeutics Recent Development
Table 134. Johnson & Johnson Company Details
Table 135. Johnson & Johnson Business Overview
Table 136. Johnson & Johnson Product
Table 137. Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 138. Johnson & Johnson Recent Development
Table 139. Marsala Biotech Company Details
Table 140. Marsala Biotech Business Overview
Table 141. Marsala Biotech Product
Table 142. Marsala Biotech Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 143. Marsala Biotech Recent Development
Table 144. Merck Company Details
Table 145. Merck Business Overview
Table 146. Merck Product
Table 147. Merck Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 148. Merck Recent Development
Table 149. Mologen AG Company Details
Table 150. Mologen AG Business Overview
Table 151. Mologen AG Product
Table 152. Mologen AG Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 153. Mologen AG Recent Development
Table 154. Oncolytics Biotech Company Details
Table 155. Oncolytics Biotech Business Overview
Table 156. Oncolytics Biotech Product
Table 157. Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 158. Oncolytics Biotech Recent Development
Table 159. Oncosec Company Details
Table 160. Oncosec Business Overview
Table 161. Oncosec Product
Table 162. Oncosec Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 163. Oncosec Recent Development
Table 164. Oncotelic Company Details
Table 165. Oncotelic Business Overview
Table 166. Oncotelic Product
Table 167. Oncotelic Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 168. Oncotelic Recent Development
Table 169. Shenzhen SiBiono GeneTech Company Details
Table 170. Shenzhen SiBiono GeneTech Business Overview
Table 171. Shenzhen SiBiono GeneTech Product
Table 172. Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 173. Shenzhen SiBiono GeneTech Recent Development
Table 174. Sillajen Biotherapeutics Company Details
Table 175. Sillajen Biotherapeutics Business Overview
Table 176. Sillajen Biotherapeutics Product
Table 177. Sillajen Biotherapeutics Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 178. Sillajen Biotherapeutics Recent Development
Table 179. Tocagen Company Details
Table 180. Tocagen Business Overview
Table 181. Tocagen Product
Table 182. Tocagen Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 183. Tocagen Recent Development
Table 184. UniQure Company Details
Table 185. UniQure Business Overview
Table 186. UniQure Product
Table 187. UniQure Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 188. UniQure Recent Development
Table 189. Ziopharm Oncology Company Details
Table 190. Ziopharm Oncology Business Overview
Table 191. Ziopharm Oncology Product
Table 192. Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2015-2020) (Million US$)
Table 193. Ziopharm Oncology Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Gene Therapy in Oncology Market Share by Type: 2020 VS 2026
Figure 2. Ex Vivo Features
Figure 3. In Vivo Features
Figure 4. Global Gene Therapy in Oncology Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostics Centers Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Gene Therapy in Oncology Report Years Considered
Figure 9. Global Gene Therapy in Oncology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Gene Therapy in Oncology Market Share by Regions: 2020 VS 2026
Figure 11. Global Gene Therapy in Oncology Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Gene Therapy in Oncology Market Share by Players in 2019
Figure 14. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy in Oncology as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy in Oncology Revenue in 2019
Figure 16. North America Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Bristol-Myers Squibb Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 25. Cold Genesys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Cold Genesys Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 27. Advantagene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Advantagene Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 29. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Amgen Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 31. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AstraZeneca Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 33. Bio-Path Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bio-Path Holdings Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 35. CRISPR Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. CRISPR Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 37. Editas Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Editas Medicine Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 39. Geron Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Geron Corp Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 41. Idera Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Idera Pharmaceuticals Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 43. Intellia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Intellia Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 45. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Johnson & Johnson Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 47. Marsala Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Marsala Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 49. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 51. Mologen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mologen AG Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 53. Oncolytics Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Oncolytics Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 55. Oncosec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Oncosec Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 57. Oncotelic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Oncotelic Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 59. Shenzhen SiBiono GeneTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Shenzhen SiBiono GeneTech Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 61. Sillajen Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Sillajen Biotherapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Figure 1. Global Gene Therapy in Oncology Market Share by Type: 2020 VS 2026
Figure 2. Ex Vivo Features
Figure 3. In Vivo Features
Figure 4. Global Gene Therapy in Oncology Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Diagnostics Centers Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Gene Therapy in Oncology Report Years Considered
Figure 9. Global Gene Therapy in Oncology Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Gene Therapy in Oncology Market Share by Regions: 2020 VS 2026
Figure 11. Global Gene Therapy in Oncology Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Gene Therapy in Oncology Market Share by Players in 2019
Figure 14. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gene Therapy in Oncology as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy in Oncology Revenue in 2019
Figure 16. North America Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Gene Therapy in Oncology Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Bristol-Myers Squibb Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 25. Cold Genesys Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Cold Genesys Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 27. Advantagene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Advantagene Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 29. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Amgen Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 31. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. AstraZeneca Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 33. Bio-Path Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bio-Path Holdings Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 35. CRISPR Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. CRISPR Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 37. Editas Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Editas Medicine Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 39. Geron Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Geron Corp Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 41. Idera Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Idera Pharmaceuticals Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 43. Intellia Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Intellia Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 45. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Johnson & Johnson Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 47. Marsala Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Marsala Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 49. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Merck Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 51. Mologen AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Mologen AG Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 53. Oncolytics Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Oncolytics Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 55. Oncosec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Oncosec Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 57. Oncotelic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Oncotelic Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 59. Shenzhen SiBiono GeneTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Shenzhen SiBiono GeneTech Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 61. Sillajen Biotherapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Sillajen Biotherapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2015-2020)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
